Optimal treatment of early-stage ovarian cancer

BACKGROUND: There is no clear consensus regarding systemic treatment of early-stage ovarian cancer (OC). Clinical trials are challenging because of the relatively low incidence and good prognosis. Initial results of the International Collaborative Ovarian Neoplasm (ICON)1 trial demonstrated benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Collinson, F., Qian, W., Fossati, R., Lissoni, A., Williams, C., Parmar, M., Ledermann, J., Colombo, N., Swart, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037858/
https://www.ncbi.nlm.nih.gov/pubmed/24631948
http://dx.doi.org/10.1093/annonc/mdu116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037858/
https://www.ncbi.nlm.nih.gov/pubmed/24631948
http://dx.doi.org/10.1093/annonc/mdu116

Ejemplares similares